Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

OPRX OptimizeRx Corporation Common Stock
$6.64 -9.54% -0.70
Notify me if price changes either direction
Interactive Brokers Logotype

Buy OPRX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

OptimizeRx Corporation Common Stock (OPRX)

Loading

Key Stats

Market cap. 125.1M
Enterprise value 129.6M
Trailing PE 30.583334
Forward PE 6.977186
PEG Ratio -0.20388889333333
Enterprise to EBITDA 8.032
Enterprise to revenue 1.376
Price to book MRQ 1.0732563
Price to sales TTM 1.4676534

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 94.2M
EBITDA 16.1M
Diluted EPS TTM 0.24
Total Cash (MRQ) 22.3M
Current ratio (MRQ) 5.059
Operating Cash Flow (TTM) 20.0M

OPRX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent OPRX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.